Transcription factors-related molecular subtypes and risk prognostic model: exploring the immunogenicity landscape and potential drug targets in hepatocellular carcinoma.

Authors:
Wang M; Guo H; Zhang B; Shang Y; Zhang S and 4 more

Journal:
Cancer Cell Int

Publication Year: 2024

DOI:
10.1186/s12935-023-03185-1

PMCID:
PMC10765642

PMID:
38178084

Journal Information

Full Title: Cancer Cell Int

Abbreviation: Cancer Cell Int

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Oncology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"raw data used to calculate the risk score is shown in additional file 9"

Code Sharing
Evidence found in paper:

"Declarations Consent for publicationAll authors approved the manuscript for publication. Competing interestsThe authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Competing interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"This study was supported by the Guiding Funds of Central Government for Supporting the Development of the Local Science and Technology (236Z3003G), One Hundred Person Project of Hebei Province (E2016100019) and the Graduate Student Innovation Funding of Hebei Normal University (CXZZSS2022064)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025